{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Warren",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91259",
      "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings DBA Haleon",
      "address_1": "184 Liberty Corner Rd",
      "address_2": "N/A",
      "postal_code": "07059-6796",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA.",
      "recall_number": "D-0183-2023",
      "product_description": "Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5",
      "product_quantity": "209,292 capsules",
      "reason_for_recall": "Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back",
      "recall_initiation_date": "20221206",
      "center_classification_date": "20230125",
      "termination_date": "20240226",
      "report_date": "20230201",
      "code_info": "Lot: R93517, R94072, R94073, Exp 02/29/2024; T00655, Exp 03/31/2025",
      "more_code_info": ""
    }
  ]
}